These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25394312)

  • 1. Chronic granulomatous disease - conventional treatment vs. hematopoietic stem cell transplantation: an update.
    Åhlin A; Fasth A
    Curr Opin Hematol; 2015 Jan; 22(1):41-5. PubMed ID: 25394312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.
    Åhlin A; Fugeläng J; de Boer M; Ringden O; Fasth A; Winiarski J
    Acta Paediatr; 2013 Nov; 102(11):1087-94. PubMed ID: 23937637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation for chronic granulomatous disease.
    Seger RA
    Immunol Allergy Clin North Am; 2010 May; 30(2):195-208. PubMed ID: 20493396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern management of chronic granulomatous disease.
    Seger RA
    Br J Haematol; 2008 Feb; 140(3):255-66. PubMed ID: 18217895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
    Bielorai B; Toren A; Wolach B; Mandel M; Golan H; Neumann Y; Kaplinisky C; Weintraub M; Keller N; Amariglio N; Paswell J; Rechavi G
    Bone Marrow Transplant; 2000 Nov; 26(9):1025-8. PubMed ID: 11100285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis and treatment of chronic granulomatous disease.
    Seger RA
    Curr Opin Hematol; 2011 Jan; 18(1):36-41. PubMed ID: 21076296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
    Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
    N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary manifestations of chronic granulomatous disease.
    Mahdaviani SA; Mohajerani SA; Rezaei N; Casanova JL; Mansouri SD; Velayati AA
    Expert Rev Clin Immunol; 2013 Feb; 9(2):153-60. PubMed ID: 23390946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Chronic Granulomatous Disease.
    Arnold DE; Heimall JR
    Adv Ther; 2017 Dec; 34(12):2543-2557. PubMed ID: 29168144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of chronic granulomatous disease - Conventional treatment vs stem cell transplantation.
    Dedieu C; Albert MH; Mahlaoui N; Hauck F; Hedrich C; Baumann U; Warnatz K; Roesler J; Speckmann C; Schulte J; Fischer A; Blanche S; von Bernuth H; Kühl JS
    Pediatr Allergy Immunol; 2021 Apr; 32(3):576-585. PubMed ID: 33118209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France.
    Beauté J; Obenga G; Le Mignot L; Mahlaoui N; Bougnoux ME; Mouy R; Gougerot-Pocidalo MA; Barlogis V; Suarez F; Lanternier F; Hermine O; Lecuit M; Blanche S; Fischer A; Lortholary O;
    Pediatr Infect Dis J; 2011 Jan; 30(1):57-62. PubMed ID: 20700078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for chronic granulomatous disease.
    Kang EM; Malech HL
    Methods Enzymol; 2012; 507():125-54. PubMed ID: 22365772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection.
    Sastry J; Kakakios A; Tugwell H; Shaw PJ
    Pediatr Blood Cancer; 2006 Sep; 47(3):327-9. PubMed ID: 16628555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical hematopoietic stem cell transplantation for a case with X-linked chronic granulomatous disease.
    Zhou L; Dong LJ; Gao ZY; Yu XJ; Lu DP
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27885760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term observational studies of chronic granulomatous disease.
    Kanariou M; Spanou K; Tantou S
    Curr Opin Hematol; 2018 Jan; 25(1):7-12. PubMed ID: 29135572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in chronic granulomatous disease.
    Goldblatt D
    J Infect; 2014 Nov; 69 Suppl 1():S32-5. PubMed ID: 25264161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.
    Connelly JA; Marsh R; Parikh S; Talano JA
    J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S31-S39. PubMed ID: 29746680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic-cell transplantation for chronic granulomatous disease.
    Thrasher A; Goldblatt D
    N Engl J Med; 2001 Aug; 345(5):377-8. PubMed ID: 11484708
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.
    Marr KA
    Curr Opin Infect Dis; 2008 Aug; 21(4):409-14. PubMed ID: 18594294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.